Christopher Febres Aldana

12PUBLICATIONS
110CO-AUTHORS
Medical mycologyMolecular targetsAtomic and molecular physicsHaematological tumoursPredictive and prognostic markers
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (12)

|Apr 20, 2026
Alternatively activated monocyte-derived myeloid cells promote extracellular pathogen persistence in pulmonary fungal granulomas.

|Jan 16, 2026
RRAS and RRAS2 Mutations Are Recurrent Oncogenic Drivers in Lung Cancer and Are Sensitive to the Pan-RAS Inhibitor RMC-6236.

Alexander J Pfeil, Tom Zhang, Ryan Cheng

|Feb 18, 2025
Pan-Cancer Analysis of Oncogenic MET Fusions Reveals Distinct Pathogenomic Subsets with Differential Sensitivity to MET-Targeted Therapy.

Christopher A Febres-Aldana, Morana Vojnic, Igor Odintsov

|Nov 07, 2024
Cellular ATP demand creates metabolically distinct subpopulations of mitochondria.

Keun Woo Ryu, Tak Shun Fung, Daphne C Baker

|Aug 26, 2024
Chromothripsis-Mediated Small Cell Lung Carcinoma.

Natasha Rekhtman, Sam E Tischfield, Christopher A Febres-Aldana

|Aug 09, 2024
HER2 Antibody-Drug Conjugates Are Active against Desmoplastic Small Round Cell Tumor.

Tom Zhang, Christopher A Febres-Aldana, Zebing Liu

Pageof 2

Frequent Collaborators

5 joint publications

Marc Ladanyi

4 joint publications

Soo-Ryum Yang

3 joint publications

Tom Zhang

3 joint publications

Marissa S Mattar